logo
Twitter
Discord
Email
logo
Molina Healthcare, Inc.

Molina Healthcare, Inc.

NYSE•MOH
CEO: Mr. Joseph Michael Zubretsky
Sector: Healthcare
Industry: Medical - Healthcare Plans
Listing Date: 2003-07-02
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Contact Information
200 Oceangate, Suite 100, Long Beach, CA, 90802, United States
562-435-3666
www.molinahealthcare.com
Market Cap
$8.71B
P/E (TTM)
9.7
vs Industry 16.5
Dividend Yield (TTM)
--
52W High
$359.97
52W Low
$151.95
52W Range
4%
5.6
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q2 2025 Data

Revenue

$11.43B+15.66%
4-Quarter Trend

EPS

$4.72-9.23%
4-Quarter Trend

FCF

-$344.00M+39.84%
4-Quarter Trend

Earnings Highlights

Key Highlights

No Data Available

Risk Factors

No Data Available

Outlook

No Data Available

Peer Comparison

Revenue (TTM)

Molina Healthcare, Inc.MOH
$43.41B
+16.1%
DaVita Inc.DVA
$13.16B
+5.1%
The Ensign Group, Inc.ENSG
$4.61B
+16.3%

Gross Margin (Latest Quarter)

Exelixis, Inc.EXEL
96.6%
-0.7 pp
BioMarin Pharmaceutical Inc.BMRN
81.8%
+0.1 pp
Align Technology, Inc.ALGN
69.9%
-0.3 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
RVTY$11.29B48.03.7%27.3%
ELAN$10.95B25.06.7%30.6%
EXEL$10.80B18.027.7%6.7%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
+3.4%
Moderate Growth
4-Quarter Net Income CAGR
-7.9%
Declining Profitability
Cash Flow Stability
50%
Cash Flow Requires Attention

Research & Insights

Reports
All Years
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 24, 2025|
    Revenue: $11.43B+15.7%
    |
    EPS: $4.72-9.2%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 24, 2025|
    Revenue: $11.15B+12.2%
    |
    EPS: $5.47+5.2%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 11, 2025|
    Revenue: $40.65B+19.3%
    |
    EPS: $20.52+9.7%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 24, 2024|
    Revenue: $10.34B+21.0%
    |
    EPS: $5.66+33.5%
    Meet
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Jul 25, 2024|
    Revenue: $9.88B+18.6%
    |
    EPS: $5.20-3.0%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: Apr 25, 2024|
    Revenue: $9.93B+21.9%
    |
    EPS: $5.20-6.0%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 13, 2024|
    Revenue: $34.07B+6.6%
    |
    EPS: $18.71+36.6%
    Beat
  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Oct 26, 2023|
    Revenue: $8.55B+7.8%
    |
    EPS: $4.24+6.3%
    Miss